Risk Evaluation and Management in Heart Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRuijin Hospital
About this trial
This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
aged 18 and above
congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema)
cardiogenic shock
Insufficient high output cardiac
Disqualifiers
expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months
Trial population
Hospitalized patients with primary discharge diagnosis of heart failure
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
All-cause mortality
Time frame
10 years2
A composite of cardiovascular events
A composite of myocardial infarction, revascularization, stroke, rehospitalization due to heart failure and cardiovascular death
Time frame
10 yearsSecondary outcomes
1
myocardial infarction
Time frame
10 years2
revascularization
Time frame
10 years3
stroke
Time frame
10 years4
rehospitalization due to heart failure
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov